Company / Gross Profit per Share
Emergent BioSolutions Inc. Gross Profit per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$6.08
FY2023
5-year range
$6.08 / $17.37
FY2019-FY2023
Trend
-18.5%
vs FY2022
Sector context
#14 of 29
Health Care
What the data says
At $6.08, Emergent BioSolutions Inc.'s gross profit per share ranks #14 of 29 in the Health Care sector. Gross Profit per Share has declined for 3 consecutive years, from $17.72 in FY2020 to $6.08 in FY2023.
Based on SEC 10-K filings.
6.08 in FY2023 with a 3-year CAGR of -30.0%.
Declined from $17.37 to $6.08 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -30.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#14 of 29 in Health CareTop 48% of 29This company $6.08 Sector average $8.10
▼
-24.9% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s gross profit per share has declined for 3 consecutive years.
- In FY2023, gross profit per share decreased 18.5% year-over-year.
- Ranks #14 out of 29 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $6.08 | -18.5% |
| FY2022 | $7.47 | -57.0% |
| FY2021 | $17.37 | -2.0% |
| FY2020 | $17.72 | - |
| FY2019 | - | - |
| FY2018 | -$0.19 | -152.3% |
| FY2017 | $0.37 | -31.6% |
| FY2016 | $0.54 | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026